相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Cost-Effectiveness of Fidaxomicin for Clostridium difficile Treatment
Matthew S. Simon
CLINICAL INFECTIOUS DISEASES (2014)
An Economic Analysis: Is Fidaxomicin Worth the Cost?
Hemal Shah et al.
CLINICAL INFECTIOUS DISEASES (2014)
Is Fidaxomicin Worth the Cost? The Verdict Is Still Out!
Abraham G. Hartzema et al.
CLINICAL INFECTIOUS DISEASES (2014)
European Society of Clinical Microbiology and Infectious Diseases: update of the treatment guidance document for Clostridium difficile infection
S. B. Debast et al.
CLINICAL MICROBIOLOGY AND INFECTION (2014)
Rifaximin in the treatment of recurrent Clostridium difficile infection
E. Mattila et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2013)
American Journal of Gastroenterology Lecture: Intestinal Microbiota and the Role of Fecal Microbiota Transplant (FMT) in Treatment of C. difficile Infection
Lawrence J. Brandt
AMERICAN JOURNAL OF GASTROENTEROLOGY (2013)
Guidelines for Diagnosis, Treatment, and Prevention of Clostridium difficile Infections
Christina M. Surawicz et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2013)
Is Fidaxomicin Worth the Cost? An Economic Analysis
Sarah M. Bartsch et al.
CLINICAL INFECTIOUS DISEASES (2013)
Challenges and opportunities for faecal microbiota transplantation therapy
G. B. Rogers et al.
EPIDEMIOLOGY AND INFECTION (2013)
Diverse Sources of C. difficile Infection Identified on Whole-Genome Sequencing
David W. Eyre et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Duodenal Infusion of Donor Feces for Recurrent Clostridium difficile
Els van Nood et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Cost-Effectiveness Analysis Evaluating Fidaxomicin versus Oral Vancomycin for the Treatment of Clostridium difficile Infection in the United States
Paul M. Stranges et al.
VALUE IN HEALTH (2013)
Epidemiology of Community-Associated Clostridium difficile Infection, 2009 Through 2011
Amit S. Chitnis et al.
JAMA INTERNAL MEDICINE (2013)
Probiotics for the prevention of Clostridium difficile-associated diarrhea in adults and children
Joshua Z. Goldenberg et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2013)
Long-Term Follow-Up of Colonoscopic Fecal Microbiota Transplant for Recurrent Clostridium difficile Infection
Lawrence J. Brandt et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2012)
Decreased Cure and Increased Recurrence Rates for Clostridium difficile Infection Caused by the Epidemic C. difficile BI Strain
Laurica A. Petrella et al.
CLINICAL INFECTIOUS DISEASES (2012)
Burden of Clostridium difficile on the Healthcare System
Erik R. Dubberke et al.
CLINICAL INFECTIOUS DISEASES (2012)
The economic burden of Clostridium difficile
S. M. McGlone et al.
CLINICAL MICROBIOLOGY AND INFECTION (2012)
The potential economic value of screening hospital admissions for Clostridium difficile
S. M. Bartsch et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2012)
Fecal Transplantation, Through Colonoscopy, Is Effective Therapy for Recurrent Clostridium difficile Infection
Eero Mattila et al.
GASTROENTEROLOGY (2012)
Treatment failure and recurrence of Clostridium difficile infection following treatment with vancomycin or metronidazole: a systematic review of the evidence
Konstantinos Z. Vardakas et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2012)
Clinical and economic burden of Clostridium difficile infection in Europe: a systematic review of healthcare-facility-acquired infection
P. N. Wiegand et al.
JOURNAL OF HOSPITAL INFECTION (2012)
Fidaxomicin versus vancomycin for infection with Clostridium difficile in Europe, Canada, and the USA: a double-blind, non-inferiority, randomised controlled trial
Oliver A. Cornely et al.
LANCET INFECTIOUS DISEASES (2012)
DECISION ANALYSIS MODEL EVALUATING THE COST-EFFECTIVENESS OF FIDAXOMICIN AND VANCOMYCIN IN THE TREATMENT OF CLOSTRIDIUM DIFFICILE INFECTION (CDI) FROM A HOSPITAL PERSPECTIVE
M. S. Alowayesh et al.
VALUE IN HEALTH (2012)
A COMPARISON OF THE COST-EFFECTIVENESS OF FIDAXOMICIN, METRONIDAZOLE, AND VANCOMYCIN, IN THE TREATMENT OF CLOSTRIDIUM DIFFICILE-ASSOCIATED DISEASE
N. Madkour et al.
VALUE IN HEALTH (2012)
HEALTH-RELATED QUALITY OF LIFE OF CLOSTRIDIUM DIFFICILE INFECTION: A METHODOLOGICAL CONTRIBUTION TO DIRECT UTILITY ELICITATION BY TTO
F. Shupo et al.
VALUE IN HEALTH (2012)
Efficacy and safety of the probiotic Saccharomyces boulardii for the prevention and therapy of gastrointestinal disorders
Theodoros Kelesidis et al.
THERAPEUTIC ADVANCES IN GASTROENTEROLOGY (2012)
Treating Clostridium difficile Infection With Fecal Microbiota Transplantation
Johan S. Bakken et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2011)
Systematic Review of Intestinal Microbiota Transplantation (Fecal Bacteriotherapy) for Recurrent Clostridium difficile Infection
Ethan Gough et al.
CLINICAL INFECTIOUS DISEASES (2011)
A randomized, double-blind, placebo-controlled pilot study to assess the ability of rifaximin to prevent recurrent diarrhoea in patients with Clostridium difficile infection
Kevin W. Garey et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2011)
Perirectal Swab Surveillance for Clostridium difficile by Use of Selective Broth Preamplification and Real-Time PCR Detection of tcdB
Scott R. Curry et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2011)
Divergent Rifamycin Susceptibilities of Clostridium difficile Strains in Canada and Italy and Predictive Accuracy of Rifampin Etest for Rifamycin Resistance
Mark A. Miller et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2011)
Host and Pathogen Factors for Clostridium difficile Infection and Colonization
Vivian G. Loo et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Fidaxomicin versus Vancomycin for Clostridium difficile Infection
Thomas J. Louie et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Management of Clostridium difficile Infection: Thinking Inside and Outside the Box
Dale N. Gerding et al.
CLINICAL INFECTIOUS DISEASES (2010)
Clinical Practice Guidelines for Clostridium difficile Infection in Adults: 2010 Update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA)
Stuart H. Cohen et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2010)
Rifaximin Redux: Treatment of recurrent Clostridium difficile infections with Rifaximin immediately post-vancomycin treatment
Stuart Johnson et al.
ANAEROBE (2009)
High Frequency of Rifampin Resistance Identified in an Epidemic Clostridium difficile Clone from a Large Teaching Hospital
Scott R. Curry et al.
CLINICAL INFECTIOUS DISEASES (2009)
Clostridium difficile 30 years on: what has, or has not, changed and why?
Dale N. Gerding
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2009)
Role of hand hygiene in healthcare-associated infection prevention
B. Allegranzi et al.
JOURNAL OF HOSPITAL INFECTION (2009)
Rifampin and rifaximin resistance in clinical isolates of Clostfdium diicile
Jennifer R. O'Connor et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Both oral metronidazole and oral vancomycin promote persistent overgrowth of vancomycin-resistant enterococci during treatment of Clostridium difficile-associated disease
Wafa N. Al-Nassir et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
The economics of Clostridium difficile -: Associated disease for providers and payers
Joseph A. Paladino et al.
CLINICAL INFECTIOUS DISEASES (2008)
Short- and long-term attributable costs of Clostridium difficile -: Associated disease in nonsurgical inpatients
Erik R. Dubberke et al.
CLINICAL INFECTIOUS DISEASES (2008)
Treatment of Clostridium difficile infection
Dale N. Gerding et al.
CLINICAL INFECTIOUS DISEASES (2008)
Comparison of clinical and microbiological response to treatment of Clostridium difficile associated disease with metronidazole and vancomycin
Wafa N. Al-Nassir et al.
CLINICAL INFECTIOUS DISEASES (2008)
Antimicrobial-associated risk factors for Clostridium difficile infection
Robert C. Owens et al.
CLINICAL INFECTIOUS DISEASES (2008)
Measures to control and prevent Clostridium difficile infection
Dale N. Gerding et al.
CLINICAL INFECTIOUS DISEASES (2008)
New advances in Clostridium difficile infection: changing epidemiology, diagnosis, treatment and control
Herbert L. DuPont et al.
CURRENT OPINION IN INFECTIOUS DISEASES (2008)
Rising economic impact of Clostridium difficile - Associated disease in adult hospitalized patient population
Xiaoyan Song et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2008)
Role of probiotics in antibiotic-associated diarrhea, Clostridium difficile-associated diarrhea, and recurrent Clostridium difficile-associated diarrhea
Christina M. Surawicz
JOURNAL OF CLINICAL GASTROENTEROLOGY (2008)
The emerging infectious challenge of clostridium difficile-associated disease in Massachusetts hospitals: Clinical and economic consequences
Judith A. O'Brien et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2007)
Asymptomatic carriers are a potential source for transmission of epidemic and nonepidemic Clostridium difficile strains among long-term care facility residents
Michelle M. Riggs et al.
CLINICAL INFECTIOUS DISEASES (2007)
A comparison of vancomycin and metronidazole for the treatment of Clostridium difficile -: Associated diarrhea, stratified by disease severity
Fred A. Zar et al.
CLINICAL INFECTIOUS DISEASES (2007)
Evaluation of Clostridium difficile -: Associated disease pressure as a risk factor for C difficile -: Associated disease
Erik R. Dubberke et al.
ARCHIVES OF INTERNAL MEDICINE (2007)
Metronidazole and vancomycin outcomes for Clostridium difficile-associated diarrhoea in a US hospital database
B. J. Lahue et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2007)
Emergence of Clostridium difficile-associated disease in North America and Europe
E. J. Kuijper et al.
CLINICAL MICROBIOLOGY AND INFECTION (2006)
A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality
VG Loo et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
An epidemic, toxin gene-variant strain of Clostridium difficile
LC McDonald et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Catheter-related fungemia caused by Saccharomyces cerevisiae in a newborn
N Belet et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2005)
Mortality attributable to nosocomial Clostridium difficile-associated disease during an epidemic caused by a hypervirulent strain in Quebec
J Pépin et al.
CANADIAN MEDICAL ASSOCIATION JOURNAL (2005)
Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe
M Warny et al.
LANCET (2005)
Increasing risk of relapse after treatment of Clostridium difficile colitis in Quebec, Canada
J Pépin et al.
CLINICAL INFECTIOUS DISEASES (2005)
Saccharomyces cerevisiae fungemia:: An emerging infectious disease
P Muñoz et al.
CLINICAL INFECTIOUS DISEASES (2005)
A large outbreak of Clostridium Difficile -: Associated disease with an unexpected proportion of deaths and colectomies at a teaching hospital following increased fluoroquinolone use
CA Muto et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2005)
Outbreak of Clostridium difficile infection in a long-term care facility:: Association with gatifloxacin use
R Gaynes et al.
CLINICAL INFECTIOUS DISEASES (2004)
Risk of Clostridium difficile diarrhea among hospital inpatients prescribed proton pump inhibitors:: cohort and case-control studies
S Dial et al.
CANADIAN MEDICAL ASSOCIATION JOURNAL (2004)
Bacteriotherapy using fecal flora - Toying with human motions
TJ Borody et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2004)
Lactobacillus bacteremia, clinical significance, and patient outcome, with special focus on Probiotic L-Rhamnosus GG
MK Salminen et al.
CLINICAL INFECTIOUS DISEASES (2004)
Favorable impact of a multidisciplinary antibiotic management program conducted during 7 years
P Carling et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2003)
Proton pump inhibitors as a risk factor for Clostridium difficile diarrhoea
R Cunningham et al.
JOURNAL OF HOSPITAL INFECTION (2003)
Recurrent Clostridium difficile colitis:: Case series involving 18 patients treated with donor stool administered via a nasogastric tube
J Aas et al.
CLINICAL INFECTIOUS DISEASES (2003)
Lactobacillus bacteremia during a rapid increase in Probiotic use of Lactobacillus rhamnosus GG in Finland
MK Salminen et al.
CLINICAL INFECTIOUS DISEASES (2002)
Health care costs and mortality associated with nosocomial diarrhea due to Clostridium difficile
L Kyne et al.
CLINICAL INFECTIOUS DISEASES (2002)
Use of a treatment protocol in the management of community-acquired lower respiratory tract infection
FA Al-Eidan et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2000)
分享论文
